Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 29 ... surgery increases the risk of progression to neovascular AMD [an advanced form of the disease involving formation of new blood vessels] in eyes at risk of progression such as those ...
2009 NOV 25 ... of T cells. However, these clonal populations are poorly studied and their role in disease initiation and progression remains unclear," scientists in Russia report. ...
2009 NOV 28 ... health outcome instrument often used for economic evaluations as a complement with disease-specific outcome measures," scientists in Hannover, Germany report."In ... generic health outcome instrument which reflects differences in health according to the progression of the life-long chronic disease cystic fibrosis."Eidtkoch and colleagues ...
2009 NOV 24 ... diagnosis of systemic sclerosis (SSc) may allow the start of treatment that could slow disease progression. For this reason early diagnosis of the disease is of pivotal importance." ...
2009 NOV 24 ... A. cordata may have a therapeutic role in preventing the progression of Alzheimer's disease." Cho and colleagues published their study in the Journal of ...
2009 NOV 29 ... A small group of patients with severe Graves' eye disease experienced rapid improvement of their symptoms - and improved vision - following ... treatment," says Douglas. "Treatment with rituximab calmed inflammation, stopped progression of the disease, and saved the patients from having to undergo ...
2009 NOV 23 ... I receive about AECOPDs: 1) Are worsening respiratory symptoms an acute exacerbation or disease progression? 2) What is the best first-line treatment for an AECOPD? 3) Would systemic steroids be ...
2009 NOV 23 ... from the protozoan Leishmania donovani, which is the causative agent of the systemic disease visceral leishmaniasis. PCNA was demonstrated to be robustly expressed in actively ... promastigotes. However, levels of expression of PCNA varied through cell cycle progression, with maximum expression evident in G1 and S phases. The subnuclear pattern of ...
2009 NOV 23 ... C Virus, Hepatocellular Cancer, Hepatocellular Carcinoma, Hepatology, Infectious Disease, Liver Disease, Oncology, Virology. This article was prepared by Clinical ... diseases, HBV and HCV infection can cause chronic injury to the liver, with subsequent progression to severe fibrosis and cirrhosis. The presence of cirrhosis is a major risk factor for ...
2009 NOV 23 ... discriminated chronic phase (CP) from blast crisis (BC) CML. In CML, phase labels divide disease progression into discrete states. BMA, however, produces posterior probabilities between 0 and 1 and ...
2009 NOV 23 ... the present study indicated that smoking modulation of bone destruction in periodontal disease may involve various osteolytic mediators, such as interleukin-1, interleukin-8, RANKL, ... Taiwan, "Cigarette smoking is a major risk factor in the development and further progression of periodontal diseases. However, little is known about how nicotine influences the ...
2009 NOV 23 ... CR may be more toxic. Although CR achievement is necessary in patients with poor-risk disease, it might not be as critical for long survival in more indolent MM. CR achievement is ... and normal bone marrow) or at least very good partial response is associated with longer progression-free survival and in most studies longer survival," scientists writing in the journal ...
2009 NOV 23 ... axonal injury and neuronal loss underlie the accumulation of disability and the disease progression. Specific treatment strategies should thus target the injury sites at the central ...
2009 NOV 23 ... from Hefei, People's Republic of China, "Cervical cancer is the most common malignant disease responsible for the deaths of a large number of women in the developing world. Although ... "STAT3 is a major oncogenic transcription factor involved in the development and progression of a number of human tumors. However, the mechanisms that result in loss of control over ...
2009 NOV 23 ... (Luminex MAP bead assay). OPG concentrations were strongly associated with global disease activity and with both renal activity on a visual analog scale (VAS) (p = 0.0006) and ... "Monocyte chemoattractant protein-1 (MCP-1), a chemotactic cytokine, is involved in the progression of glomerular and tubulointerstitial injury. We investigated both urine OPG and MCP-1 as ...
2009 NOV 24 ... The researchers concluded: "These features should guide future research into disease progression, and identify those patients needing intensive treatment." Loebinger and ...
2009 NOV 23 ... are looking for a treatment that is well-tolerated, safe and effective against this disease," said Bruce Montgomery, M.D., lead investigator of ARMOR1 and associate professor, ... in the United States annually. The only therapy currently approved for the treatment of progression of CRPC is the chemotherapeutic docetaxel. New therapies are needed to specifically ...
2009 NOV 23 ... imaging agent for measuring and monitoring cathepsin B activity associated with disease progression and therapeutic response in vivo. Cathepsin B expression is well known as a key ...
2009 NOV 23 ... very promising, indicating a potentially new drug to help control this life-threatening disease with acceptable safety and quality of life," commented George Demetri, MD, Director of ... trial, with 65 treated and 61 eligible for analysis. The 61 patients were evaluated for progression-free survival (PFS) with 20 documented PFS events (doxorubicin alone = 14 events; ...
